Accelerate research, empower industry

Hysigen Bioscience is a prominent global biotechnology enterprise that integrates R&D, services, and products, specializing in gene editing in cell lines and animal models. Established in 2015 by a cohort of eminent scientists from China and the United States, Hysigen Bioscience embodies a pioneering force in the field of life sciences.

Leveraging its profound technological expertise, Hysigen Bioscience is devoted

to providing exceptional gene editing services to a broad clientele. Our valued customers range across basic research, drug development and translational medicine.